HTLV-II Endemicity among Guaymi Indians in Panama
- 21 February 1991
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 324 (8) , 565
- https://doi.org/10.1056/nejm199102213240815
Abstract
Human T-cell lymphotropic virus Type II (HTLV-II), the second human retrovirus to be discovered, has recently been found to be endemic among intravenous drug users in the United States and Europe.1 2 3 4 In addition, about half the blood donors in the United States who are seropositive for HTLV-I/II appear to be infected with HTLV-II.5 Little is known about the transmission of HTLV-II or the diseases associated with it. This lack of knowledge renders it difficult to counsel persons, such as blood donors, who are found to be infected with the virus. The identification of a population in which HTLV-II is endemic other than intravenous drug users (who are difficult to study and are at risk for many diseases) would offer an opportunity to learn more about this virus.Keywords
This publication has 8 references indexed in Scilit:
- Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in Panama.Proceedings of the National Academy of Sciences, 1990
- Human T Cell Lymphotropic Virus Infection in Guaymi Indians from PanamaThe American Journal of Tropical Medicine and Hygiene, 1990
- HTLV-II infection in Italian drug abusersThe Lancet, 1990
- Seroepidemiology of Human T Cell Lymphotropic Virus in the Republic of PanamaThe American Journal of Tropical Medicine and Hygiene, 1990
- High Prevalence of HTLV-II Among Intravenous Drug Abusers: PCR Confirmation and TypingAIDS Research and Human Retroviruses, 1990
- Prevalence of human T-cell leukemia/lymphoma virus (HTLV) type II infection among high-risk individuals: type-specific identification of HTLVs by polymerase chain reactionBlood, 1989
- High Rate of HTLV-II Infection in Seropositive IV Drug Abusers in New OrleansScience, 1989
- Characterization of a Sequence of Human T Cell Leukemia Virus Type I from a Patient with Chronic Progressive MyelopathyThe Journal of Infectious Diseases, 1988